The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Gündogdu, Mehtap S ^a   Liu, He ^b,c   Metzdorf, Daniela ^a   Hildebrand, Dagmar ^a   Aigner, Michael ^d   Aktories, Klaus ^b   Heeg, Klaus ^a   Kubatzky, Katharina F ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; JANUS KINASE; PROTEIN RHOH; RECOMBINANT INTERLEUKIN 3; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; STAT PROTEIN; STAT1 PROTEIN; STAT5 PROTEIN; TYROSINE; UNCLASSIFIED DRUG; CDKN1A PROTEIN, MOUSE; CDKN1B PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; RHOH PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEMATOPOIETIC CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; METABOLISM; PHYSIOLOGY; UPREGULATION;

MURINAE;

ANIMALS; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; INTERLEUKIN-3; MICE; RECEPTORS, INTERLEUKIN-3; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 77955825509     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-225     Document Type: Article

References (38)

1. Madaule P, Axel R. A novel ras-related gene family. Cell 1985, 41:31-40. 10.1016/0092-8674(85)90058-3, 3888408.
2. Bar-Sagi D, Hall A. Ras and Rho GTPases: a family reunion. Cell 2000, 103:227-238. 10.1016/S0092-8674(00)00115-X, 11057896.
3. Vojtek AB, Der CJ. Increasing complexity of the Ras signaling pathway. J Biol Chem 1998, 273:19925-19928. 10.1074/jbc.273.32.19925, 9685325.
4. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635. 10.1038/nature01148, 12478284.
5. Dallery E, Galiegue-Zouitina S, Collyn-d'Hooghe M, Quief S, Denis C, Hildebrand MP, Lantoine D, Deweindt C, Tilly H, Bastard C, et al. TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation. Oncogene 1995, 10:2171-2178.
6. Didsbury J, Weber RF, Bokoch GM, Evans T, Snyderman R. rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem 1989, 264:16378-16382.
7. Li X, Bu X, Lu B, Avraham H, Flavell RA, Lim B. The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol Cell Biol 2002, 22:1158-1171. 10.1128/MCB.22.4.1158-1171.2002, 134637, 11809807.
8. Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL, Der CJ. Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene 1998, 17:1415-1438. 10.1038/sj.onc.1202181, 9779988.
9. Gu Y, Chae HD, Siefring JE, Jasti AC, Hildeman DA, Williams DA. RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development. Nat Immunol 2006, 7:1182-1190. 10.1038/ni1396, 17028588.
10. Fueller F, Kubatzky KF. The small GTPase RhoH is an atypical regulator of haematopoietic cells. Cell Commun Signal 2008, 6:6. 10.1186/1478-811X-6-6, 2565660, 18823547.
11. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001, 412:341-346. 10.1038/35085588, 11460166.
12. Galiegue-Zouitina S, Delestre L, Dupont C, Troussard X, Shelley CS. Underexpression of RhoH in Hairy Cell Leukemia. Cancer Res 2008, 68:4531-4540. 10.1158/0008-5472.CAN-07-5661, 18559497.
13. Iwasaki T, Katsumi A, Kiyoi H, Tanizaki R, Ishikawa Y, Ozeki K, Kobayashi M, Abe A, Matsushita T, Watanabe T, et al. Prognostic implication and biological roles of RhoH in acute myeloid leukaemia. Eur J Haematol 2008, 81:454-460. 10.1111/j.1600-0609.2008.01132.x, 18691253.
14. Gu Y, Jasti AC, Jansen M, Siefring JE. RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival, migration, and engraftment of hematopoietic progenitor cells. Blood 2005, 105:1467-1475. 10.1182/blood-2004-04-1604, 15494435.
15. Chae HD, Lee KE, Williams DA, Gu Y. Cross-talk between RhoH and Rac1 in regulation of actin cytoskeleton and chemotaxis of hematopoietic progenitor cells. Blood 2008, 111:2597-2605. 10.1182/blood-2007-06-093237, 2254535, 18089848.
16. Dorn T, Kuhn U, Bungartz G, Stiller S, Bauer M, Ellwart J, Peters T, Scharffetter-Kochanek K, Semmrich M, Laschinger M, et al. RhoH is important for positive thymocyte selection and T-cell receptor signaling. Blood 2007, 109:2346-2355. 10.1182/blood-2006-04-019034, 17119112.
17. Daryadel A, Yousefi S, Troi D, Schmid I, Schmidt-Mende J, Mordasini C, Dahinden CA, Ziemiecki A, Simon HU. RhoH/TTF negatively regulates leukotriene production in neutrophils. J Immunol 2009, 182:6527-6532. 10.4049/jimmunol.0803846, 19414807.
18. Oda H, Fujimoto M, Patrick MS, Chida D, Sato Y, Azuma Y, Aoki H, Abe T, Suzuki H, Shirai M. RhoH plays critical roles in Fc epsilon RI-dependent signal transduction in mast cells. J Immunol 2009, 182:957-962.
19. Yousefi S, Cooper PR, Mueck B, Potter SL, Jarai G. cDNA representational difference analysis of human neutrophils stimulated by GM-CSF. Biochem Biophys Res Commun 2000, 277:401-409. 10.1006/bbrc.2000.3678, 11032736.
20. Migliaccio G, Migliaccio AR, Visser JW. Synergism between erythropoietin and interleukin-3 in the induction of hematopoietic stem cell proliferation and erythroid burst colony formation. Blood 1988, 72:944-951.
21. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC, Nawa Y, Dranoff G, Galli SJ. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998, 392:90-93. 10.1038/32190, 9510253.
22. Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science 1996, 271:818-822. 10.1126/science.271.5250.818, 8629001.
23. Liu X, Constantinescu SN, Sun Y, Bogan JS, Hirsch D, Weinberg RA, Lodish HF. Generation of mammalian cells stably expressing multiple genes at predetermined levels. Anal Biochem 2000, 280:20-28. 10.1006/abio.2000.4478, 10805516.
24. Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y, Fu XY. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996, 272:719-722. 10.1126/science.272.5262.719, 8614832.
25. Mui AL, Wakao H, O'Farrell AM, Harada N, Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J 1995, 14:1166-1175. 398194, 7720707.
26. Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 1994, 14:4335-4341. 358804, 8007942.
27. Mui AL, Wakao H, Kinoshita T, Kitamura T, Miyajima A. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J 1996, 15:2425-2433. 450174, 8665850.
28. Testa U, Riccioni R, Militi S, Coccia E, Stellacci E, Samoggia P, Latagliata R, Mariani G, Rossini A, Battistini A, et al. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 2002, 100:2980-2988. 10.1182/blood-2002-03-0852, 12351411.
29. Guzman ML, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Phillips GL, Jordan CT. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells. Blood 2001, 97:2177-2179. 10.1182/blood.V97.7.2177, 11264190.
30. Tian SS, Tapley P, Sincich C, Stein RB, Rosen J, Lamb P. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Blood 1996, 88:4435-4444.
31. Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci USA 1996, 93:7673-7678. 10.1073/pnas.93.15.7673, 38805, 8755534.
32. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996, 84:443-450. 10.1016/S0092-8674(00)81289-1, 8608598.
33. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996, 84:431-442. 10.1016/S0092-8674(00)81288-X, 8608597.
34. Parada Y, Banerji L, Glassford J, Lea NC, Collado M, Rivas C, Lewis JL, Gordon MY, Thomas NS, Lam EW. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression. J Biol Chem 2001, 276:23572-23580. 10.1074/jbc.M101885200, 11323429.
35. Akala OO, Clarke MF. Hematopoietic stem cell self-renewal. Curr Opin Genet Dev 2006, 16:496-501. 10.1016/j.gde.2006.08.011, 16919448.
36. Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 2000, 19:2496-2504. 10.1038/sj.onc.1203486, 10851048.
37. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 1988, 18:97-104. 10.1002/eji.1830180115, 2831066.
38. Kubatzky KF, Liu W, Goldgraben K, Simmerling C, Smith SO, Constantinescu SN. Structural requirements of the extracellular to transmembrane domain junction for erythropoietin receptor function. J Biol Chem 2005, 280:14844-14854. 10.1074/jbc.M411251200, 15657048.